Andrea Sbrana
- Health top 10%
-
- Cancer Immunotherapy and Biomarkers 10
- Neutropenia and Cancer Infections 5
- Pancreatic and Hepatic Oncology Research 3
-
- Cannabis and Cannabinoid Research 4
-
- Renal cell carcinoma treatment 8
- Lung Cancer Treatments and Mutations 6
- Prostate Cancer Treatment and Research 5
-
- Economic and Financial Impacts of Cancer 4
- Co-authors
- Andrea AntonuzzoAlfredo FalconeLuca GalliMarco DanovaLodovico BalducciGuido MiccinesiMichael SilbermannChristina M. Puchalski
- Cited by
- HealthOncologyPharmacology
- Journals
- Journal of Clinical Oncology (7 papers)Annals of Oncology (6 papers)Supportive Care in Cancer (4 papers)
- Partner nations
- ItalyUnited StatesFrance
In The Last Decade
Andrea Sbrana
49 papers receiving 447 citations
Peers
Comparison fields: 5 of 77
- Health 58
- Oncology 144
- Pharmacology 80
- Pulmonary and Respiratory Medicine 106
- Otorhinolaryngology 12
Countries citing papers authored by Andrea Sbrana
This map shows the geographic impact of Andrea Sbrana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Sbrana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Sbrana more than expected).
Fields of papers citing papers by Andrea Sbrana
This network shows the impact of papers produced by Andrea Sbrana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Sbrana. The network helps show where Andrea Sbrana may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrea Sbrana, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 5 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 13 | |
| 8 | 2023 | 21 | |
| 9 | 2022 | 1 | |
| 10 | 2022 | 17 | |
| 11 | 2021 | 6 | |
| 12 | 2020 | 2 | |
| 13 | 2020 | 7 | |
| 14 | 2020 | 10 | |
| 15 | 2019 | 77 | |
| 16 | 2018 | 7 | |
| 17 | 2018 | 3 | |
| 18 | 2017 | 4 | |
| 19 | 2016 | 1 | |
| 20 | 2016 | 2 |
About Andrea Sbrana
Andrea Sbrana is a scholar working on Oncology, Otorhinolaryngology, Pulmonary and Respiratory Medicine, Internal Medicine and Statistics and Probability, having authored 52 papers that have together received 452 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Renal cell carcinoma treatment (8 papers), Lung Cancer Treatments and Mutations (6 papers), Neutropenia and Cancer Infections (5 papers), Prostate Cancer Treatment and Research (5 papers), Economic and Financial Impacts of Cancer (4 papers), Cannabis and Cannabinoid Research (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). The work is most often cited by research in Health (58 citations), Oncology (144 citations), Pharmacology (80 citations), Pulmonary and Respiratory Medicine (106 citations) and Otorhinolaryngology (12 citations). Andrea Sbrana has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Andrea Antonuzzo, Alfredo Falcone, Luca Galli, Marco Danova, Lodovico Balducci, Guido Miccinesi, Michael Silbermann, Christina M. Puchalski, Carla Ripamonti and Tracy A. Balboni. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Supportive Care in Cancer, Future Oncology and ESMO Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.